Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Metastases × Mitomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 34 Non-Muscle Invasive Bladder Neoplasms 22 Colorectal Neoplasms 18 Anus Neoplasms 16 Carcinoma, Transitional Cell 14 Carcinoma, Hepatocellular 11 Appendiceal Neoplasms 10 Stomach Neoplasms 9 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 8 Peritoneal Neoplasms 7 Pancreatic Neoplasms 7 Lung Neoplasms 6 Liver Neoplasms 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Neoplasms 4 Carcinoma 4 Sarcoma 3 Recurrence 3 Pseudomyxoma Peritonei 3 Ovarian Neoplasms 3 Mesothelioma, Malignant 3 Gastrointestinal Neoplasms 3 Breast Neoplasms 3 Anal Canal Carcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Head and Neck Neoplasms 2

Interventions

trisacryl gelatin microspheres 1 Zoledronic Acid 1 Radiosurgery 1 Mitomycin 1 Ethiodized Oil 1 Chemoembolization, Therapeutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04200417 2025-05-16

Chemoembolization for Lung Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡